Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 784.45

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (1738)	3/19/2015 4:56:37 PM
From: Biotech Jim	Read Replies (1) of 3559

Endothelial cells on the CNS blood vasculature have "tight junctions" and as such form the blood brain barrier. When these cells contract, the tight junction is lost and that is when the blood-brain barrier is breached. That is the basis for my speculation on potential direct or indirect effects on these endothelial cells that comprise the blood-brain barrier. I am not convinced that the data provides for a 'real' effect on stroke incidence.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next